Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis
Abstract Background Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Despite treatment being in line with current guidelines, mortality remains high in those with septic shock. Intravenous immunoglobulins represent a promising therapy to modulate bo...
Main Authors: | Axel Nierhaus, Giorgio Berlot, Detlef Kindgen-Milles, Eckhard Müller, Massimo Girardis |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-10-01
|
Series: | Annals of Intensive Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13613-020-00740-1 |
Similar Items
-
Efficacy of an IgM preparation in the treatment of patients with sepsis: a double-blind randomized clinical trial in a pediatric intensive care unit
by: Ermira Kola, et al.
Published: (2015-12-01) -
Efficacy of an IgM preparation in the treatment of patients with sepsis: a double-blind randomized clinical trial in a pediatric intensive care unit
by: Ermira Kola, et al.
Published: (2015-12-01) -
Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis
by: Hao Wei, et al.
Published: (2021-02-01) -
Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid
by: Stanislav Khil'chenko, et al.
Published: (2020-09-01) -
Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections
by: Jeroen D. Langereis, et al.
Published: (2018-08-01)